Cargando…
Therapeutic inertia in proteinuria management among type 2 diabetes (T2DM) patients in primary care settings: prevalence and associated risk factors
BACKGROUND: Therapeutic inertia (TI), defined as physicians’ failure to increase therapy when treatment goals are unmet, is an impediment to chronic disease management. This study aimed to identify the prevalence of TI in proteinuria management among T2DM patients managed in primary care settings an...
Autores principales: | Chan, FU Leung, Li, Yim Chu, Chen, Xiao Rui Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215779/ https://www.ncbi.nlm.nih.gov/pubmed/34148542 http://dx.doi.org/10.1186/s12875-021-01455-3 |
Ejemplares similares
-
Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and
methods to overcome inertia
por: Khunti, Sachin, et al.
Publicado: (2019) -
Adherence, control of cardiometabolic factors and therapeutic inertia in patients with type 2 diabetes in the primary care setting
por: Orozco‐Beltrán, Domingo, et al.
Publicado: (2021) -
Nonadherence, Clinical Inertia, or Therapeutic Inertia?
por: Allen, J. Daniel, et al.
Publicado: (2009) -
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
por: Khunti, Kamlesh, et al.
Publicado: (2017) -
Therapeutic Inertia and Delays in Insulin Intensification in Type 2 Diabetes: A Literature Review
por: Gavin, James R., et al.
Publicado: (2023)